Montelukast Prescribing at WHITBY GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,583
Total Quantity
42.3K
NHS Cost
£2.3K
vs National Avg
+131.2%
WHITBY GROUP PRACTICE prescribed 1,583 items of Montelukast over the last 12 months at a cost of £2,315 to the NHS. This is 131.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
139
Jun 2026
124
Jun 2026
122
Jun 2026
127
Jun 2026
144
Jun 2026
137
Jun 2026
131
Jun 2026
150
Jun 2026
139
Jun 2026
122
Jun 2026
137
Jun 2026
111
Prescribing Details
| Total Items | 1,583 |
|---|---|
| Total Quantity | 42,347 |
| Total NHS Cost | £2,315 |
| Presentations | 4 different forms |
| vs National Average | +131.2% |
Montelukast Prescribing Comparison
| This practice | 1,583 items |
|---|---|
| National average per practice | 685 items |
| Difference | +131.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.